Literature DB >> 4378689

Pharmacology of oxazepam (Serax), a new anti-anxiety agent.

M I Gluckman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 4378689

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


× No keyword cloud information.
  6 in total

1.  Reversal of the effect of centrally-administered diazepam on morphine antinociception by specific (Ro 15-1788 and Ro 15-3505) and non-specific (bicuculline and caffeine) benzodiazepine antagonists.

Authors:  F Zambotti; N Zonta; R Tammiso; P Ferrario; B Hafner; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

2.  The effect of Valium anaesthesia on the radiosensitivity of the skin of the mouse foot.

Authors:  E M Fröhlich; H Fritz-Niggli
Journal:  Experientia       Date:  1980-03-15

3.  Effects of oxazolam, cloxazolam, and CS-386, new anti-anxiety drugs, on socially induced suppression and aggression in pairs of monkeys.

Authors:  T Kamioka; I Nakayama; S Akiyama; H Takagi
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

4.  Modification of the antinociceptive effect of morphine by centrally administered diazepam and midazolam.

Authors:  P Mantegazza; M Parenti; R Tammiso; P Vita; F Zambotti; N Zonta
Journal:  Br J Pharmacol       Date:  1982-04       Impact factor: 8.739

5.  Zopiclone potentiates the antinociceptive effect of morphine in rats.

Authors:  F Zambotti; N Zonta; R Tammiso; F Conci; B Hafner; P Ferrario; L Zecca; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

6.  Curcumin can prevent the changes in cerebellar structure and function induced by sodium metabisulfite in rat.

Authors:  Ali Noorafshan; Ali Rashidiani-Rashidabadi; Saied Karbalay-Doust; Aghdas Poostpasand; Mohammad-Amin Abdollahifar; Reza Asadi-Golshan
Journal:  Exp Neurobiol       Date:  2013-12-31       Impact factor: 3.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.